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Abstract
Background: Interactions between biological entities such as genes, proteins and metabolites, so called pathways,
are key features to understand molecular mechanisms of life. As pathway information is being accumulated rapidly
through various knowledge resources, there are growing interests in maintaining the integrity of the
heterogeneous databases.
Methods: Here, we defined conflict as a status where two contradictory pieces of evidence (i.e. ‘A increases B’ and
‘A decreases B’) coexist in a same pathway. This conflict damages unity so that inference of simulation on the
integrated pathway network might be unreliable. We defined rule and rule group. A rule consists of interaction of
two entities, meta-relation (increase or decrease), and contexts terms about tissue specificity or environmental
conditions. The rules, which have the same interaction, are grouped into a rule group. If the rules don’t have a
unanimous meta-relation, the rule group and the rules are judged as being conflicting.
Results: This analysis revealed that almost 20% of known interactions suffer from conflicting information and
conflicting information occurred much more frequently in the literature than the public database.
With consideration for dual functions depending on context, we thought it might resolve conflict to consider
context. We grouped rules, which have the same context terms as well as interaction. It’s revealed that up to 86%
of the conflicts could be resolved by considering context.
Subsequent analysis also showed that those contradictory records generally compete each other closely, but some
information might be suspicious when their evidence levels are seriously imbalanced.
Conclusions: By identifying and resolving the conflicts, we expect that pathway databases can be cleaned and
used for better secondary analyses such as gene/protein annotation, network dynamics and qualitative/quantitative
simulation.
Background
The recent advent of molecular experiment and analysis
technologies has led to an unprecedented success in dis-
covering novel biological knowledge including biomedi-
cal entities and their interactions, or pathways. Pathways
are at the center of modern biology by describing how
biological molecules affect each other to emerge and
manage life phenomena. Particularly, the entity-relation
based model is the core of systems biology. Therefore,
retrieving, collecting and integrating pathways relevant
to a specific study constitute the most important first
step.
Integrating pathway information is, however, not trivial.
Most of currently known pathways data are only partially
centralized for all the efforts to standardize syntax and
ontology. Except a few cases, pathway data are physically
scattered according to their biological domains. Some
exist as a form of database, usually after confirming the
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reliability of the information by experts, or manual cura-
tion (MC) [1]. Databases provide a highly robust informa-
tion source for researchers. However, their knowledge
ranges are usually limited due to the laborious manual
procedures. On the contrary, automated information
extraction upon the millions of published studies, or litera-
ture mining (LM) covers ideally unlimited ranges of
human knowledge [2]. In spite of the information quantity
that LM provides, pathways recruited from LM can be
suspicious due to several types of artifacts such as low lit-
erature quality and text mining errors. In this regards,
integrating pathways from both MC and LM is required to
compensate shortcomings from each resource.
Here we noticed an important but largely unexplored
problem in the integrated biological pathways - a conflict.
Information from different sources can be sometimes
contradictory; for instance, one source may say a protein
P activates a gene G’s transcription, but at the same time,
another source may say P represses G’s transcription.
This can be a desperate case for many researchers who
rely on previously studied results. And we may want to
ask several questions: 1) how much of the pathway infor-
mation has conflict? 2) What causes conflicts? And 3)
within a conflict, which one is more reliable? Stobbe et
al. tried to answer a part of those questions by identifying
consensus information among five different metabolic
pathway databases [3]. Surprisingly, only 3% consensus
was found among 6968 shared metabolic reactions.
We extended the concept of conflict to consider cellu-
lar context in the pathways. Context is basically an aug-
ment information set in a pathway; cell-type, organ,
disease and drug. With a context, a pathway is more spe-
cified by the range where the context is true. For
instance, “protein P activates gene G’s transcription” can
be specified like followings: “P activates G’s transcription
in brain”, “P activates G’s transcription in T-cells or
“P activates G’s transcription in schizophrenia”. By con-
sidering contexts, we can prevent many false positive
conflicts that are in fact non-contradictory pathways that
do not overlap each other. Ajibade et al. discovered that
TAK1-TAB1 complex works in a dual way [4]. TAK-
TAB1 activates NF-B signaling pathway in mouse
embryonic fibroblasts; however, in neutrophils, TAK1
binding prevents TAB1 from activating NF-B signaling
pathway (Figure 1). It indicates that there may exist enti-
ties playing a role in some manner in one cell type but
completely the opposite way in another cell type.
The context-dependent conflict analysis shows us how
an integrated pathway dataset (from heterogeneous
sources) should be handled. We found that an unex-
pectedly high portion of pathways (~20%) contain con-
flicting information. Thus, before continuing to the
secondary analysis, conflicting rules must be taken care
of. Cellular context information should be extracted at
the highest level to distinguish false positive conflicts
from true and specific conflicts. With a balance analysis,
however, we also figured out that resolving conflicts by
elimination (discarding one side of conflicts) is not tri-
vial due to the tight competition between their evidence
levels. But we could also check some obvious erroneous
information from a part of them. We expect that subse-
quent studies on resolving conflicts, simulating over-
conflicted pathways and measuring evidence level will
dramatically improve the quality of our systems analysis.
Methods
Constructing an integrated biological pathway dataset
We first constructed a large-scale biological pathway set
to interrogate the existence of conflicting information in
our current knowledge. The pathway set consists of two
major information resources for publicly reported biolo-
gical pathways: a public canonical database and biome-
dical literatures.
Information extraction from public pathway database
We used the KEGG pathway database [5] as the test base
of canonical pathways. Although the KEGG does not
represent the entire pathway database, it provides highly
reliable information through 281 manually confirmed
human pathways that contain directional relationships
between biomedical entities. Also, many associated tools
and libraries enable a robust information extraction. At
first, we extracted relation information from four canoni-
cal curated pathway databases including KEGG, PID,
SMPDB, and ReconX. Among various types of conflict,
we chose the conflict where contradictory information
(i.e. ‘A increases B’ and ‘A decreases B’) exist in a same
interaction. In case of ‘react’ or ‘translocate’ relation, it’s
not straight forward to choose which relations are con-
tradictory with ‘react’ or ‘translocate’. Most information
in the databases except KEGG contains ‘react’ or ‘translo-
cate’ information. In case of protein-protein interactions,
the information is not used because they have no direc-
tion. We, therefore, only used the relation information in
KEGG. Nonetheless, other pathway databases (i.e. Bio-
Carta) can be added for additional analysis.
We downloaded KEGG Markup Language (KGML)
files of 281 human pathways from KEGG pathway data-
base using KEGGgraph package in R [6]. KGML files
contain a set of records each of which consists of an
entry field and a relation between two entities. We
could further confirm the relational information using a
KEGG ID (i.e. has:1432) in the entry field. Each relation
has two entities, entity1 and entity2 where entry1 acts
on entry2. Relations are annotated with interaction
types (i.e. gene regulation, protein-protein interaction,
and protein-chemical interaction) and subtypes (i.e. acti-
vation, inhibition, phosphorylation, dephosphorylation,
glycosylation, ubiquitination, methylation, indirect effect,
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missing interaction, expression, repression, binding/asso-
ciation, dissociation, and reaction).
Based on the KGML file structure, we extracted 41,207
type/subtype-annotated relations among 5,457 biomedi-
cal entities.
Information extraction from biomedical literatures
Relations among biological entities were extracted from
13,214,710 PubMed abstracts. To accomplish this, we
first tagged entities from the literatures using a set of
existing Named Entity Recognition (NER) tools; different
NER tools were used to tag different entity types.
We defined eight biomedical entity types including
‘gene’, ‘protein’, ‘cell type’, ‘disease’, ‘organ’, ‘metabolite’,
‘drug’ and ‘biological process’. Based on the reported per-
formance of NER tools using a manually curated corpus
[7,8], we selected one best tool for each entity type. By
this criterion, four NER tools were selected; Genia [9] for
tagging ‘gene’, ‘protein’ and ‘cell type’, BANNER [10] for
‘disease’, LingPipe [11] for ‘organ’ and NERSuite [12] for
‘metabolite’, ‘drug’ and ‘biological process’. According to
the papers explaining the methods (see Table 1), we
chose tools to extract each type of biological entities. The
performances of GENIA was better than BANNER. Data-
set which is used were, however, different. So we could
not compare each other. These are the reason why we
chose GENIA. The running time of GENIA was shorter
than that of BANNER. And the coverage of GENIA was
wider than that of BANNER, for example GENIA can
find cell type in a literature.
We considered that a sentence in a literature contains a
relational information particularly when the relational
word (i.e. increase, activate or repress) is located between
two biomedical entities (see Table 2). For example, ‘acti-
vate’ is located between ‘CYP1A’ and ‘benzo[a]pyrene’ in
following sentence; “In contrast, CYP1A isoforms can
also activate some compounds, such as benzo[a]pyrene
to their carcinogenic metabolite, and the induction of
these isoforms increases the risk of carcinogenicity.”.
In this manner, totally 2,575,846 relations among
53,799 entities have been extracted from literature.
Figure 1 Dual function of TAK1. In mouse embryonic fibroblasts (MEFs), TAK1-TAB1 complex activates NF-B signaling pathway to protect cells
from apoptosis. However, in neutrophils, TAK1 binding prevents TAB1 from activating NF-B signaling pathway, resulting in cell apoptosis.
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Mapping relations to meta-relations
To investigate the consistency and inconsistency among
interactions, we mapped the collected relationships
between entities in the integrated pathways to two
meta-relations, ‘increase’ and ‘decrease’. As the word
‘meta-relation’ stands for, ‘increase’ and ‘decrease’ are
not confined to their literal meanings, but include all
the possible relations in which one entity affects the
other in a positive or negative way. For instance,
‘increase’ may represent (but not be limited to) 1)
increase of molecular quantity (i.e. activation of mRNA
transcription), 2) activation of gene/protein functions
(i.e. signal transduction by phosphorylation) and
3) induction of phenotypes (i.e. triggering of apoptosis
or causing a disease). The ‘decrease’ meta-relation can
be defined in a similar way.
We observed totally 14 relational terms from the
KEGG database containing [’activation’, ‘inhibition’,
‘phosphorylation’, ‘dephosphorylation’, ‘glycosylation’,
‘ubiquitination’, ‘methylation’, ‘indirect effect’, ‘missing
interaction’, ‘expression’, ‘repression’, ‘binding/associa-
tion’, ‘dissociation’, and ‘reaction’]. Among the 14, five
relations including ‘activation’, ‘phosphorylation’, ‘glyco-
sylation’ ‘methylation’ and ‘expression’ have been
mapped to the ‘increase’ meta-relation. On the other
hands, three relations including ‘inhibition’, ‘depho-
sphorylation’ and ‘repression’ have been mapped to the
‘decrease’ meta-relation. The remaining six terms could
not be mapped due to their ambiguity in functional
directionality.
In the biomedical literature pathways, we found 64
distinct relations (see Table 3). We mapped 36 relations
to ‘increase’ and 28 relations to ‘decrease’.
We considered the form of sentence to annotate the
extracted meta-relations to their corresponding entities.
When a sentence was written in an active form (i.e. “A
increases B”), we regarded the former entity as the act-
ing one and the latter as its target. On the contrary, we
switched the roles of two entities when a sentence was
written in a passive form (i.e. “A is increased by B”). We




To identify relations that are valid under only a specific
condition, we defined and considered four types of context:
organ (OG), cell- type (CT), disease (DS) and drug (DR).
Organ and cell-type context provides the location
where the corresponding relation arises. For instance, a
statement ‘A increases B in liver (OG)’ constraints the
relation’s effect range to liver. Cell-type is similarly
defined. Disease and drug context provides the clinical
effect range of the corresponding relation with respect to
phenotypic and environmental conditions respectively.
For instance, ‘A decreases B in lung adenocarcinoma
(DS)’ or ‘A increases B in (or given) Herceptin’ can be
interpreted in a similar way.
To build the ontology of four different contexts, we
obtained 1,191 organ, 526 cell-type and 4,620 disease
terms from MeSH (Medical Subject Heading) database
[13] (Table 4). For drug context, we used 6,825 terms
from the DrugBank database [14]. Totally, 13,162 context
terms were prepared for subsequent context information
extraction.
Extraction of context information
Based on the 13,162 context terms, we attempted to
extract the context information associated to each rela-
tion in the constructed integrated biological pathway set.
Given that the canonical pathway database does not
Table 1. Performance of each tool
Types Tools Date Prec. Recall F-score Choice DataSet Time*
Chemical CheNER 2013 91% 30% 50% O EvalC Corpus 21 min
ChemSpot 2012 75% 84% 79% X 210 min
Gene/
Protein
GENIA tagger 2006 66% 81% 72% O NLPBA2004
(Protein)
9 min
NERsuite 2012 88% 82% 85% X BioCreative2 11 min
ABNER 2005 68% 78% 73% X
BANNER 2008 87% 83% 85% X 60 min
Alias-i LingPipe
(LIPI)
2010 60% 70% 64% X
Cell type GENIA tagger 2006 79% 71% 74% O NLPBA dataset 9 min
ABNER 2005 80% 66% 72% X
Disease BANNER 2008 87% 83% 85% O NCBI Disease Corpus 58 min
Organ Alias-i LingPipe
(LIPI)
2010 O NCBI’s GeneTag Corpus 16 min
Time* is time for which it takes to tag entities within 5,000 abstracts.
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contain any additional information other than entity-rela-
tion sets, the attachment of context information was only
available for literature driven pathways.
We first searched for the defined context terms in the
entire biomedical literatures. For the case that a context
term c was discovered in a literature L, we annotated all
the relations that have been extracted within L with c.
When multiple context terms were found, we took the
following approach. If the multiple terms consist of dis-
tinct context types (OG, CT, DS and/or DR), we anno-
tated corresponding relations with the entire context set.
If there are more than two context terms of a same type,
we separated them into a set of single context to generate
new relations, each of which is annotated with one con-
text. In other words, context terms of different types are
connected by an AND-like operation (i.e. ‘A increases B
in liver under Aspirin’) whereas context terms of a same
type are OR-like (i.e. ‘A decreases B in liver or lung’).
This strategy is consistent with the rationale that two
same type contexts are not satisfiable simultaneously (i.e.
there is no liver and stomach organ) or are rarely com-
bined in a literature (i.e. ‘stomach cancer and breast can-
cer’ usually denotes two separated conditions).
Identifying conflicting information
Based on the integrated biological pathway set with con-
text information, we search for all conflicting (or contra-
dictory) information that the set harbors.
Basic definitions
We define an interaction i as a set of two entities and
the associated meta-relation:
i = {LEFT-ENTITY, RIGHT-ENTITY, META-
RELATION}
, where the LEFT-ENTITY is a biomedical entity (i.e.
gene or protein) that plays an acting role in the relation,
the RIGHT-ENTITY is a target biomedical entity, and
the META-RELATION is the relation between LEFT-
ENTITY and RIGHT-ENTITY mapped to either of the
previously defined ‘increase’ or ‘decrease’ relationship
(see Methods 2.2). By this definition, one interaction
corresponds to one edge in the context-free biological
pathway.
We define a rule r as a set of two entities, meta-rela-
tion between the entities and the associated context
information:
r = {LEFT-ENTITY, RIGHT-ENTITIY, META-RELA-
TION, CT, OG, DS, DR}
Table 2. Pairs of entities in meta-relations


































Table 3. Mapping table
Relations Meta-relation
phosphorylate, glycosylate, acetylate, accelerate, accumul, activat, add, agoni, amplif, augment, elevat, encod, enhanc, enrich,
express, generat, hyperexpr, improv, increas, increment, induc, mediat, overexpress, overproduc, produc, releas, result, secret,
stimulat, synthesis, transactivat, transcri, translat, trigger, up-regulat, yield
Increase
attenuat, block, dephosphorylat, deacetylat, abolish, abrogat, antagoni, counteract, declin, decreas, degrad, deplet, depress,
destruct, diminish, down-regulat, inactivat, inhibit, interfer, interrupt, obstruct, oppos, prevent, prohibit, reduc, remov, repress,
suppress
Decrease
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, where CT, OG, DS, DR are sets of cell-type, organ,
disease, drug context term(s) respectively. The context
term fields can be ‘null’ where no information was
extracted. To exemplify the rule, two sample rules are
denoted below, where r1 contains three context terms
(CT, OG and DS) and r2 has no context information.
r1 = {protein X, gene Y, increase, epithermal cell,
small intestine, T2D, ‘null’}.
r2 = {protein A, gene B, decrease, ‘null’, ‘null’, ‘null’,
‘null’}
By definition, each interaction has a set of supporting
rules (at least one rule). We define a rule group of an
interaction i, R(i) as the set of rules the share the same
LEFT-ENTITY and RIGHT-ENTITY:
R(i) = {r | r[1]=i[1], r[2]=i[2]}
, where r[1], r[2], i[1], i[2] denotes the LEFT-ENTITY
and the RIGHT-ENTITY of the rule r and the interac-
tion i (as the way of referring an element by the address
in the set). The rule group is further divided into two
sub groups by the directionality of meta-relation. An
increase rule group R(i)+ and a decrease rule group R(i)-
of an interaction i are defined as:
R(i)+ = {r | r[1]=i[1], r[2]=i[2], r[3]=’increase’}
R(i)- = {r | r[1]=i[1], r[2]=i[2], r[3]=’decrease’}
, where r[3] is the META-RELATION of the rule r.
Judgment of conflict
For an interaction i and its supporting rule group R(i),
we generally expect the entire set R(i) to be uni-direc-
ted, which means the observed relations between two
entities should be consistent. Likewise, the coexistence
of contradictory information (i.e. ‘A increases B’ and ‘A
decreases B’) is exceptional and needs to be resolved for
a proper downstream pathway analysis.
We call an interaction i has conflicting information
where both of increase and decrease rules are contained
in its supporting rule group. Using the previous defini-
tion, this condition can be defined as:
N(R(i)+) > 0 and N(R(i)-) > 0.
The number of conflicts in i is calculated as the sum of
the number of rules, N(R(i)+) + N(R(i)-).
Judgment of context-dependent conflict
Using the context information, the effect range of a rela-
tion could be constrained (see Methods 2.3). Thus, a con-
flict between two rules that have non-overlapping effect
ranges can be resolved. For instance, a rule ‘A increases B
in liver’ and ‘A decreases B in adipocyte’ can be non-con-
tradictory. Based on the annotated context, we further
extend the definition of conflicting information. So, a
context-dependent conflict arises only between rules that
have identical context information. Formally, a rule sub-
group of an interaction i, R(i, OG, CT, DS, DR) is defined
as a subset of R(i) that have the corresponding context.
R(i, OG, CT, DS, DR) = {r | r[1]=i[1], r[2]=i[2], r[4]
=CT, r[5]=OG, r[6]=DS, r[7]=DR}
The possible number of subgroups is the number of
combinations among four contexts.
Similarly, an increase rule subgroup and a decrease
rule subgroup can be defined:
R(i, OG, CT, DS, DR)+ = {r | r[1]=i[1], r[2]=i[2], r[3]
=’increase’, r[4]=CT, r[5]=OG, r[6]=DS, r[7]=DR}
R(i, OG, CT, DS, DR)- = {r | r[1]=i[1], r[2]=i[2], r[3]
=’decrease’, r[4]=CT, r[5]=OG, r[6]=DS, r[7]=DR}
Therefore, context-dependent conflict arises when an
increase rule subgroup and the corresponding decrease
rule subgroup are both non-empty.
Balance analysis among conflicting rules
We call two rule groups R(i)+ and R(i)- or two rule sub-
groups R(i, OG, CT, DS, DR)+ and R(i, OG, CT, DS,
DR)- are competitive if they conflict. A balance relation-
ship between two conflicting rule groups can be inferred
from the number of supporting rules. We call a rule
group is strong if the number of the group is bigger
than that of its competing group, and weak otherwise.
To see if a conflict is dominated by one rule group,
we define a minor rule frequency MRF as the size ratio
of weak rule group over the whole rule groups:
MRF = min(N(R(i)+), N(R(i)-)) / (N(R(i)+) + N
(R(i)-))
, where min(A, B) is the smaller number between A
and B. An MRF near 0.5 denotes that two rule groups
are supported in a similar level. A very small MRF may
implicit the weak rule group resulted from erroneous lit-
erature information or mining procedures. We call a
conflict is dominating if MRF < 0.25 and balanced
otherwise.
Table 4. Statistics of four contexts and their resources
Context Class Context Type # Terms Ref. DB
Locational Organ (OG) 1,191 MeSH
Cell Type (CT) 526
Clinical Disease (DS) 4,620
Drug (DR) 6,825 DrugBank
Total 13,162
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Results
Integrated pathway networks
We constructed the integrated pathway networks consist
of 810,073 interactions (edges) among 53,799 biomedical
entities from a canonical curated pathway database
(KEGG database) and literatures. The 810,073 edges are
comprised of 2,575,846 rules (see Methods). To show
the overall shape of the integrated pathway network, we
visualized a part of the whole network (about 5%) using
Cytoscape [15] (Figure 2 left); drawing the entire net-
work was computationally intractable. The average
number of neighbors in the network was 4.5 and the
characteristic path length was 4.7.
Among rules which are collected by parsing KEGG
database, it’s showed that 89% of interaction of them are
also found in the interactions extracted by literature
mining. This indirectly validated the accuracy of the
extraction process.
Conflicting information in integrated pathway networks
We found 157,065 out of 810,073 interactions (19.4%)
contain conflicting information. The 157,065 conflicting
interactions were supported by 1,564,315 rules (out of
2,575,846 rules, 60.7%). The ratio of conflicting interac-
tion was unexpectedly high, showing that the collection
of biological interactions suffers from self-inconsistency.
The overall distribution of conflicts is depicted as red
edges in Figure 2.
We found the ratio of conflicting interactions is
dependent on the pathway resources. When using
KEGG only, the ratio was extremely small 310 out of
35,845 (0.86%) to imply that most of the conflicting
information came from literature mining. This is consis-
tent with our expectation that pathways from more reli-
able sources contain conflicting information in a lower
level.
Analysis of context-dependent conflicts
As we described in Methods, a conflict between two
entities can be resolved by constraining the effect range
of the supporting rules. We applied four types of con-
texts, cell-type (CT), organ (OG), disease (DS), and drug
(DR), to analyze the portion of the context-dependent
conflicts.
To identify the effect of each context type, we applied
the combination of the four contexts (16 cases) to the
pre-identified conflicts. When applying each combina-
tion of context C (C is a subset of {CT, OG, DS, DR}),
we took the following approach. First, we generated a
rule subgroup (see Methods) R(i, C) with respect to the
context combination from the rule group of an interac-
tion i, R(i). Second, we classified the rule subgroup into
an increase rule subgroup R(i, C)+ and R(i, C)-. Third,
we counted the rules in the rule subgroup for which
both increase and decrease rule subgroups are non-
empty.
We found the ratio of conflicting rule groups have
been dramatically reduced up to 13.6 % when consider-
ing contexts (Figure 3). Intuitively, application of more
number of contexts resolves more conflicts. The result
Figure 2 Overall shape of a partial integrated pathway and ratios of conflicting interaction.
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is consistent with the intuition; however, the effect of
single context was significant too.
In general, we found the effect of locational contexts
(organ and cell-type) is stronger than that of clinical
context (disease and drug). This may imply that molecu-
lar functions and interactions in a cell vary more widely
depending on the organs and tissue types. A well-known
explanation of this is a tissue-specific regulation. Yu et
al. identified 6,232 putative cis-regulatory modules regu-
lating 2,130 tissue specific genes [16]. On the other
hands, drugs are likely to change gene regulation and
molecular activities in a more narrow way to target a
specific function.
Balance analysis of competing rules
Conflicts can be seen as a competition between two
contradictory rule groups (increase versus decrease).
There are many possible causes of the conflicts. One is
that one rule group is supported by unreliable informa-
tion. Some of the pathway sources contain erroneous
information or there could be erroneous procedures in
information curation and extraction. Some supporting
literatures contain false discoveries, old hypothesis or
discarded biological knowledge. The other possibility is
that both rules are not wrong. Genes may function in a
dual way or their functions are differed by unconsidered
contexts.
Balance analysis is to see if one group is dominantly
supporting than the other. As described in Methods, a
minor rule frequency (MRF) can work as an indicator of
the balance. A severe imbalance may imply one rule
group is wrong. By definition, we call a conflict is a
dominating conflict when MRF is less than 0.25, and
balanced otherwise.
We calculated MRF values for 203,885 conflicting rule
groups that have been filtered by four contexts (Figure 4).
We found most of the conflicts are balanced. Out of
203,885 rule groups, 192,197 (94.3%) had MRF values lar-
ger than 0.25. On the contrary, only 11,688 (5.73%) rule
groups had MRF values less than 0.25. Therefore, we con-
clude that there is insufficient evidence to eliminate one
relation (a specific ‘increase’ or ‘decrease’ rule group) and
it is necessary to consider more context types to resolve
the conflicts; such contexts may include measurement
time, ethnic origin or dependency between other entities.
We calculated MRF values for 310 conflicting rule
groups in KEGG. Out of 310 rule groups, 283 (91.3%)
were balanced conflicts. On the contrary, 27 (8.71%)
were dominating conflicts. There are fewer conflict
among rule groups from KEGG, and the most conflict
are balanced conflict, too.
Case study: dominating conflicts
We analyzed some of dominating conflicts showing very
small MRF, and discovered that main reason of unba-
lance is due to text mining error.
For example, the following sentence is a sentence in
PMID15799207 of PubMed; “Effective control of growth
hormone should, with long-term use, reduce morbidity
and mortality from acromegaly and has been shown to
result in partial involution of the pituitary adenoma in the
majority of treated patients.” A rule was extracted, it had
‘growth’ which was tagged as a LEFT-ENTITY and ‘pitui-
tary adenoma’ which was tagged as a RIGHT-ENTITY.
Figure 3 Percentage of conflicting R(i, C)s.
Figure 4 Histogram of MRF for conflicting R(i, C)s.
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This rule had not to be extracted, but it was extracted as a
rule in decrease rule subgroup. This error occurred because
‘reduce’ between the two entities was tagged as a relation
word. A true verb as a relation word of the two entities is
‘has been shown’, and wrongly tagged ‘reduce’ is used to
mean that effective control of growth hormone reduces
morbidity and mortality from acromegaly.
A sentence in PMID19759287 is “... a specific form of
neuronal death induced by NMDAR overstimulation,
dramatically decreases Kidins220/ARMS levels in corti-
cal neurons and in a model of cerebral ischemia.” A
rule was extracted. It had ‘neuronal death’ which was
tagged as a LEFT-ENTITY and ‘cerebral ischemia’ which
was tagged as a RIGHT-ENTITY. This rule had not to
Figure 5 Dual function of genes. a show dual function of VEGFA in proteoglycans in cancer pathway, and b shows dual function of NKD1 in
WNT pathway.
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be extracted, but it was extracted as a rule in decrease
rule subgroup. This error occurred because ‘decrease’
between the entities was tagged as a relation. Here,
‘decreased’ is used to mean that exitotoxicity reduces
Kidins220/ARMS.
Case study: balanced conflicts
We analyzed some balanced conflicts. There are cases
where difference of context which were not yet consid-
ered or informed, make conflict. Here are some exam-
ples. Vascular endothelial growth factor A (VEGFA)
inhibits tumor angiogenesis. But it activates when bound
to matrix [17]. This dual function is also shown in ‘pro-
teoglycans in cancer pathway’ in KEGG (Figure 5a).
Naked cuticle homolog 1 (NKD1) inhibits dishevelled
segment polarity protein 1 (DV1) in canonical WNT sig-
nalling pathway. It, however, activates DV1 in Planar cell
polarity (PCP) WNT pathway [18]. This is also in ‘WNT
signalling pathway’ in KEGG (Figure 5b).
Discussion
Number of conflicts and resource quality
We measured and analyzed the conflicting rule groups
from literature and a public database. As a result, con-
flicting rule groups occurred much more frequently in
the literature than the public database, indicating that the
public database are more reliable than literature mining.
From this conclusion, we would be able to assign weights
as reliability to rules based on its resource. Then, we
could adjust the weights when we perform simulation or
inference on constructed networks.
Improving literature mining techniques
The measurement of conflicts among data extracted by
literature mining can be used to identify literature
mining errors. Dominating conflicts, which are heavily
weighted on one side (either R(i)+ or R(i)-), may be
results of literature mining mistakes. Thus, through
checking the weak rule groups, we could easily identify
where literature mining process were incorrect. By find-
ing and correcting these literature mining mistakes, lit-
erature mining techniques can be improved, resulting in
more precise results.
Biological meaning of balanced conflicts
Contrary to dominating conflicts, some conflicts have
fairly even distribution on the both sides. We can con-
sider these balanced conflicts as being due to dual func-
tions rather than simple literature mining mistakes.
Actually, some entities, even though they lie in the same
context, have dual functions to the same object for the
homeostasis and robustness of a biological process [19].
We expect that we could discover new dual functions
by analyzing these balanced conflicts.
Conclusion
In this study, we introduced a novel systematic analysis
for identifying biological pathways with conflict informa-
tion. The unexpectedly high rate of conflicts could be
explained by two different ways: context specific dual
functions and erroneous information. We provided a
novel scoring measure, minor rule frequency (MRF), as
a potential discriminatory feature for extracting novel
dual-role information. By cleaning pathway information,
we expect all subsequent analysis including network
connectivity, dynamics and association based annotation
to be improved and more useful in the current data-dri-
ven research era.
Abbreviations
KEGG: Kyoto encyclopedia of genes and genomes; MC: manual curation; LM:
literature mining; KGML: KEGG Markup Language; NER: Named Entity
Recognition; OG: organ; CT: cell-type; DS: disease; DR: drug; MeSH: Medical
Subject Heading; MRF: minor rule frequency; VEGFA: Vascular endothelial
growth factor A; NKD1: Naked cuticle homolog 1; DV1: dishevelled segment
polarity protein 1; PCP pathway: Planar cell polarity pathway
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DL and SK developed idea of this research and supported writing article. SY
wrote article, extracted rule from literatures with KP and DJ, and make an
algorithm to judge conflict of rules. JJ and HY wrote article, extracted rule
from KEGG, and draw graphs. MK analyzed conflicting rules and draw
graphs. SC searched previous works and draw graphs.
Acknowledgements
This work was supported by the Bio-Synergy Research Project
(2012M3A9C4048758)
This work was supported by the faculty research grant of Yonsei University
College of Medicine for (6-2014-0067).
Declarations
Publication costs for the article were sourced from Doheon Lee who is one
of corresponding authors.
This article has been published as part of BMC Medical Informatics and
Decision Making Volume 15 Supplement 1, 2015: Proceedings of the ACM
Eighth International Workshop on Data and Text Mining in Biomedical
Informatics. The full contents of the supplement are available online at
http://www.biomedcentral.com/bmcmedinformdecismak/supplements/15/S1.
Authors’ details
1Department of Bio and Brain Engineering, KAIST, 291 Daehak-ro, Yuseong-
gu, Daejeon 305-701, Republic of Korea. 2Severance Biomedical Science
Institute, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-
gu, Seoul 120-752, Republic of Korea.
Published: 20 May 2015
References
1. Kamburov A, Pentchev K, Galicka H, Wierling C, Lehrach H, Herwig R:
ConsensusPathDB: toward a more complete picture of cell biology.
Nucleic acids research 2011, 39(suppl 1):D712-D717.
2. Cerami EG, Gross BE, Demir E, Rodchenkov I, Babur Ö, Anwar N, Schultz N,
Bader GD, Sander C: Pathway Commons, a web resource for biological
pathway data. Nucleic acids research 2011, 39(suppl 1):D685-D690.
3. Stobbe MD, Swertz MA, Thiele I, Rengaw T, Van Kampen AH, Moerland PD:
Consensus and conflict cards for metabolic pathway databases. BMC
systems biology 2013, 7(1):50.
Yoon et al. BMC Medical Informatics and Decision Making 2015, 15(Suppl 1):S3
http://www.biomedcentral.com/1472-6947/15/S1/S3
Page 10 of 11
4. Ajibade AA, Wang HY, Wang RF: Cell type-specific function of TAK1 in
innate immune signaling. Trends in immunology 2013, 34(7):307-316.
5. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes.
Nucleic acids research 2000, 28(1):27-30.
6. Ihaka R, Gentleman R: R: a language for data analysis and graphics.
Journal of computational and graphical statistics 1996, 5(3):299-314.
7. Nobata C, Dobson PD, Iqbal SA, Mendes P, Tsujii Ji, Kell DB, Ananiadou S:
Mining metabolites: extrt the yeast metabolome from the literature.
Metabolomics 2011, 7(1):94-101.
8. Cheng D, Knox C, Young N, Stothard P, Damaraju S, Wishart DS:
PolySearch: a web-based text mining system for extracting relationships
between human diseases, genes, mutations, drugs and metabolites.
Nucleic acids research 2008, 36(suppl 2):W399-W405.
9. Tsuruoka Y, Tateishi Y, Kim J-D, Ohta T, McNaught J, Ananiadou S, Tsujii Ji:
Developing a robust part-of-speech tagger for biomedical text. Advances
in informatics. Springer; 2005, 382-392.
10. Leaman R, Gonzalez G: BANNER: an executable survey of advances in
biomedical named entity recognition. Pacific Symposium on Biocomputing:
2008 2008, 652-663.
11. LingPipe 2.3.0. [http://www.alias-i.com/lingpipe].
12. NERsuite: A Named Entity Recognition toolkit. [http://nersuite.nlplab.org].
13. Lipscomb CE: Medical subject headings (MeSH). Bulletin of the Medical
Library Association 2000, 88(3):265.
14. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B,
Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and
drug targets. Nucleic acids research 2008, 36(suppl 1):D901-D906.
15. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N,
Schwikowski B, Ideker T: Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome
research 2003, 13(11):2498-2504.
16. Yu X, Lin J, Zack DJ, Qian J: Identification of tissue-specific cis-regulatory
modules based on interactions between transcription factors. BMC
bioinformatics 2007, 8(1):437.
17. Shibuya M: Structure and dual function of vascular endothelial growth
factor receptor-1 (Flt-1). The international journal of biochemistry & cell
biology 2001, 33(4):409-420.
18. Bangi E, Wharton K: Dual function of the Drosophila Alk1/Alk2 ortholog
Saxophone shapes the Bmp activity gradient in the wing imaginal disc.
Development 2006, 133(17):3295-3303.
19. Hart Y, Antebi YE, Mayo AE, Friedman N, Alon U: Design principles of cell
circuits with paradoxical components. Proceedings of the National
Academy of Sciences 2012, 109(21):8346-8351.
doi:10.1186/1472-6947-15-S1-S3
Cite this article as: Yoon et al.: Context-based resolution of semantic
conflicts in biological pathways. BMC Medical Informatics and Decision
Making 2015 15(Suppl 1):S3.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Yoon et al. BMC Medical Informatics and Decision Making 2015, 15(Suppl 1):S3
http://www.biomedcentral.com/1472-6947/15/S1/S3
Page 11 of 11
